PFBN1 Protein

PFBN1 Protein (Profilin 1)

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f8e8; text-align:center; font-size:1.1em;">PFBN1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Profilin 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[PFBN1](/genes/pfbn1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8WU66](https://www.uniprot.org/uniprot/Q8WU66)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Profilin-1, PFN1</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~15 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Profilin family</td></tr>
</table>
</div>

Overview

Profilin 1 (PFBN1) is a small actin-binding protein that plays essential roles in actin cytoskeleton dynamics, cell motility, and neuronal function. While best characterized for its critical role in actin polymerization, PFBN1 has been strongly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/als). Notably, mutations in PFBN1 cause early-onset familial ALS, definitively establishing its critical role in motor neuron survival.

Structure and Function

Profilin Fold

PFBN1 adopts the classic profilin structural fold:

PFBN1 Protein (Profilin 1)

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f8e8; text-align:center; font-size:1.1em;">PFBN1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Profilin 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[PFBN1](/genes/pfbn1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8WU66](https://www.uniprot.org/uniprot/Q8WU66)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Profilin-1, PFN1</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~15 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Profilin family</td></tr>
</table>
</div>

Overview

Profilin 1 (PFBN1) is a small actin-binding protein that plays essential roles in actin cytoskeleton dynamics, cell motility, and neuronal function. While best characterized for its critical role in actin polymerization, PFBN1 has been strongly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/als). Notably, mutations in PFBN1 cause early-onset familial ALS, definitively establishing its critical role in motor neuron survival.

Structure and Function

Profilin Fold

PFBN1 adopts the classic profilin structural fold:

• Seven β-strands: Form the protein core and create the binding interface
• Two α-helices: N-terminal and C-terminal helices contribute to function
• Poly-L-proline binding site: Recognizes proline-rich sequences in various proteins
• Actin binding interface: Contacts G-actin to regulate polymerization

Molecular Functions

PFBN1 executes multiple essential cellular functions:

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis

PFBN1 is directly linked to ALS pathogenesis:

• Dominant mutations: PFBN1 mutations cause familial ALS
• Motor neuron degeneration: Loss of PFBN1 function leads to motor neuron death
• Cytoskeletal disruption: Mutations disrupt actin dynamics essential for neuronal function
• Stress granule dynamics: PFBN1 associates with stress granules under cellular stress

Alzheimer's Disease

In Alzheimer's disease, PFBN1 is involved in critical processes:

• Synaptic function: PFBN1 regulates dendritic spine actin structure
• Axonal transport: Cytoskeletal proteins affect vesicle trafficking
• [Tau](/proteins/tau) pathology: Interactions with tau phosphorylation pathways
• Synaptic plasticity: PFBN1 modulates activity-dependent morphological changes

Parkinson's Disease

In Parkinson's disease, PFBN1 contributes to essential functions:

• Dendritic complexity: Loss of PFBN1 affects neuronal morphology
• Axonal degeneration: Cytoskeletal disruption contributes to PD pathogenesis
• [Alpha-synuclein](/proteins/alpha-synuclein) dynamics: Interactions with aggregation pathways
• Mitochondrial function: PFBN1 affects mitochondrial dynamics

Molecular Mechanisms

PFBN1 dysregulation leads to neurodegeneration through:

Therapeutic Potential

Target Validation

PFBN1 represents a validated therapeutic target for ALS and other neurodegenerative diseases:

• Gene therapy: Restoring PFBN1 function in affected [neurons](/entities/neurons)
• Small molecule stabilizers: Compounds that stabilize PFBN1 structure
• Cytoskeletal modulators: Targeting downstream effector pathways

Biomarker Applications

PFBN1 levels may serve as important biomarkers:

• Diagnostic marker: PFBN1 in CSF or blood samples
• Disease progression indicator: Correlation with clinical severity
• Therapeutic response marker: Treatment effects on PFBN1 levels

See Also

• Actin Cytoskeleton in Neurodegeneration
• ALS Genetics and Mechanisms
• Cytoskeletal Proteins in AD
• [Axonal Transport Defects](/mechanisms/axonal-transport-defects)

References